Serum ghrelin and prediction of metabolic parameters in over 20-year follow-up
•The longest follow-up study on the predictive role of ghrelin on CV risk factors.•High plasma ghrelin protects from increase of blood pressure.•Ghrelin levels did not predict the development of abnormalities in glucose tolerance. Ghrelin is a peptide hormone from the stomach, with an ability to rel...
Gespeichert in:
Veröffentlicht in: | Peptides (New York, N.Y. : 1980) N.Y. : 1980), 2016-02, Vol.76, p.51-56 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •The longest follow-up study on the predictive role of ghrelin on CV risk factors.•High plasma ghrelin protects from increase of blood pressure.•Ghrelin levels did not predict the development of abnormalities in glucose tolerance.
Ghrelin is a peptide hormone from the stomach, with an ability to release growth-hormone from the pituitary. Numerous cross-sectional studies indicate that ghrelin also has a role in metabolic abnormalities, such as metabolic syndrome and type 2 diabetes, but evidence for long-term effect is scarce. We investigated, whether ghrelin concentration measured in middle age would predict the development or absence of metabolic disturbances subsequently. Study population consisted of 600 middle-aged persons, and the follow-up time was approximately 21 years. Plasma total ghrelin concentration was measured at the baseline, and divided to tertiles. Numerous anthropometric and other clinical measurements (including blood pressure), and laboratory test were made both at the baseline and at the follow-up. After the follow-up the prevalence of high systolic blood pressure according to MetS IDF-criteria was the lowest in the highest ghrelin tertile, and the highest in the first (p |
---|---|
ISSN: | 0196-9781 1873-5169 |
DOI: | 10.1016/j.peptides.2015.12.002 |